Teledermatology company Curology raises $15M to scale direct-to-consumer subscription skincare

By Heather Mack
Share

San Diego, California-based Curology, which offers prescription skincare products based on smartphone photos and an online questionnaire, patient-provided information, raised $15 million in Series B funding. The round was led by Advance Vixeid Partners, with participation from prior investors Sherpa Capital and Forerunner Ventures.

The funding will be used to expand Curology’s offering: an end-to-end online solution wherein users remotely share photos of their skin with a licensed medical professional employed by Curology.

Users take an online questionnaire (which asks about their medical history, current regimen and skincare goals), then upload three high-resolution photos. Each patient then gets a bottle with three active ingredients customized for their skin, which is adjusted based on how their skin reacts over time.

The mission is to address the common skin conditions that are not life-threatening, but often highly impact a person’s daily life: acne and the signs of aging. While personalized, prescription treatments can offer the best results, for whatever reason, not everyone is able to visit a dermatologist.

 "In the US, there is only one dermatologist for every 36,000 people – and most are concentrated in major metro areas, meaning access to specialists is limited. As a result, many consumers settle for inadequate over-the-counter remedies," Dr. David Lortscher, CEO and founder of Curology said in a statement. "With Curology, they get one-on-one dermatology care and personalized, prescription strength treatment for just $20 per month."